Sarah Cannon and HCA Research Institute — Nashville, Tennessee

Sarah Cannon and HCA Research Institute is a clinical research site located in Nashville, Tennessee, United States 37221.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Sarah Cannon and HCA Research Institute has participated in 13 clinical trials with 9 currently active.

Therapeutic areas: Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer.

Sponsors: BicycleTx Limited, Matthew Neal MD, Ipsen.

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon and HCA Research Institute?

Sarah Cannon and HCA Research Institute has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon and HCA Research Institute conducted?

Sarah Cannon and HCA Research Institute has 13 clinical trials on record, with 9 currently active. Their work covers Advanced Solid Tumor Historically Known for High EphA2 Expression, Urothelial Cancer, Ovarian Cancer.

Is Sarah Cannon and HCA Research Institute accredited by Crixeo Health?

Yes — Sarah Cannon and HCA Research Institute holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Sarah Cannon and HCA Research Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.